Vitamin B-12 deficiency in the elderly: Current dilemmas

American Journal of Clinical Nutrition

Volumn 66, Issue 4, 1997, Pages 741-749

  Stabler, Sally P ^a   Lindenbaum, John ^b   Allen, Robert H ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Cobalamin; Dementia; Elderly; Folate; Homocysteine; Methylmalonic acid; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID;

AGED; ALZHEIMER DISEASE; COMORBIDITY; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; HUMAN; HYPERHOMOCYSTEINEMIA; MEGALOBLASTIC ANEMIA; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0030881762     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.4.741     Document Type: Review

References (79)

1. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992;40:1197-204.
2. Lindenbaum J, Rosenberg I, Wilson P, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
3. Joosten E, Van Den Berg A, Reizler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in the elderly. Am J Clin Nutr 1993;58:468-76.
4. 12) deficiency using the urinary MMA assay by gas chromatography/mass spectrometry. Am J Med 1993;94:589-94.
5. Joosten E, Pelemons W, Devos P, et al. Cobalamin absorption and serum homocysteine and MMA in elderly subjects with low serum cobalamin. Eur J Haematol 1993;51:25-30.
6. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Am J Clin Nutr 1994;60:2-11.
7. 12 concentration in older people: a case control study. J Am Geriatr Soc 1996;44:1355-61.
8. 6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995;346:85-9.
9. Ubbink JB, Becker PJ, Vermaak WJH, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995;41:1033-7.
10. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ, ed. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker Inc, 1992:183-236.
11. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
12. Stampfer MJ, Malinow MR, Willett WC, et al. Prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;68:877-81.
13. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;4:704-9.
14. Glueck CJ, Shaw P, Lange JE, Tracy T, Sieve-Smith L, Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995;75:132-6.
15. Selhub J, Jacques PF, Boston AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995;332:286-91.
16. Robinson K, Mayer ELI, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate: independent and reversible risk factors for coronary artery disease. Circulation 1995;92:2825-30.
17. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-97.
18. Rosenberg LE, Fenton WA. Disorders of propionate and methylmalonate metabolism. In: Scriver C, Beaudet A, Sly W, Valle D, eds. Metabolic basis of inherited disease. New York: McGraw-Hill, 1989:821-44.
19. Kovachy RJ, Copley SD, Allen RH. Recognition, isolation and characterization of rat liver D-methylmalonyl-coenzyme A hydrolase. J Biol Chem 1983;258:11415-21.
20. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Elevation of 2-methylictric acid I and II levels in serum, urine and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42:978-88.
21. Mudd SH, Levy HL, Skovby F. Disorder of transsulfuration. In: Scriver C, Beaudet A, Sly W, Valle D, eds. Metabolic basis of inherited disease. New York: McGraw-Hill, 1989:693-734.
22. Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993;42:1448-60.
23. Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J 1990;4:1450-9.
24. 12 deficiency. Clin Chim Acta 1962;18:197-204.
25. 12 (cobalamin) deficiency to prevent permanent neurologic disability. GC/MS News 1984;12:120-9.
26. Stabler SP, Marcell PD, Podell ER, et al. Assay of MMA in the serum of patients with cobalamin deficiency using capillary gas chromatography/mass spectrometry. J Clin Invest 1986;77:1606-12.
27. Ho CH, Chang HC, Yeh SF. Quantitation of urinary methylmalonic acid by gas chromatography mass spectrometry and its clinical applications. Eur J Haematol 1987;38:80-4.
28. 12 deficiency. Ann Intern Med 1987;106:707-10.
29. Moelby L, Rasmussen K, Jensen MK, Pedersen KO. The relationship between clinically confirmed cobalamin deficiency and serum methylmalonic acid. J Intern Med 1990;228:373-8.
30. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum MMA and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
31. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987;36:458-62.
32. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine B-synthase deficiency. Metabolism 1988;37:175-8.
33. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography/mass spectrometry. J Clin Invest 1988;81:466-74.
34. 12 or folate deficiency. Eur J Haematol 1994;52:227-32.
35. 6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 1992;55:1154-60.
36. 6 status on homocysteine metabolism. J Clin Invest 1996;98:177-84.
37. Soria C, Chadefaux B, Coude M, Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 1990;36:21-37.
38. Hultberg A, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993;40:230-4.
39. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentrations. Scand J Clin Lab Invest 1996;56:41-6.
40. Rasmussen K, Vyberg B, Pedersen KO, Brochner-Mortensen J. Methylmalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990; 36:1523-4 (letter).
41. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma level in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
42. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
43. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990;76:871-81.
44. Lindenbaum J, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency. II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:99-107.
45. Allen RH, Stabler SP, Savage D, Lindenbaum J. Diagnosis of cobalamin deficiency I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:90-8.
46. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
47. Healton EB, Savage DG, Brust JCM, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine 1991;70:229-45.
48. Sumner AE, Chin MM, Abrahm JL, Gerry GT, Allen RH, Stabler SP. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B-12 deficiency after gastric surgery. Ann Intern Med 1996;124:469-76.
49. Matchar DB, McCrory DC, Millington DS, Feussner JR. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci 1994;308:276-83.
50. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13.
51. Koehler KM, Romero LJ, Stauber PM, et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996;4:364-76.
52. Carmel R, Gott PS, Waters CH, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995;54:245-53.
53. Joosten E, Lesaffre R, Reizler R. Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people. Eur J Haematol 1996;57:222-6.
54. Rasmussen K, Moller J, Lyngbak M, Pedersen AMH, Dybkjer L. Age-and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
55. 12 and iron deficiency in infants on macrobiotic diets. Am J Clin Nutr 1989;50:818-24.
56. Dagnelie PC, van Staveren WA, Verschuren SAJM, Hautvast JGAJ. Nutritional status of infants aged 4 to 18 months on macrobiotic diets and matched omnivorous control infants: a population-based mixed-longitudinal study. I. Weaning pattern, energy and nutrient intake. Eur J Clin Nutr 1989;43:311-23.
57. Schneede J, Dagnelie PC, van Staveren WA, Vollset SE, Refsum H, Ueland PM. Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res 1994;36:194-201.
58. 12 in Alzheimer-type dementia. Age Ageing 1984;148:1705-7.
59. Karnaze DS, Carmel R. Low serum cobalamin levels in primary degenerative dementia: do some patients harbor atypical cobalamin deficiency states? Arch Intern Med 1987;147:429-31.
60. Kristensen MO, Gulmann NC, Christensen JEJ, Ostergaard K, Rasmussen K. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 1993;87:475-81.
61. Nilsson K, Gustafson L, Faldt R, Andersson A, Hultbert B. Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 1994;24:600-6.
62. 12: effects of replacement therapy on dementia. J Neurol 1996;243:522-9.
63. Martin DC, Francis J, Protetch J. Time dependence of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-72.
64. 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx longitudinal aging study. J Am Geriatr Soc 1994;42:933-6.
65. US Department of Health and Human Services, US Department of Agriculture. Ten-year comprehensive plan for the National Nutrition Monitoring and Related Research Program. Fed Regist 1993;58:32752-806.
66. 12 deficiency. J Nutr 1996;126:1266S-72S.
67. Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ. Results of an international round robin for serum and whole-blood folate. Clin Chem 1996;42:689-94.
68. Brown RD, Jun R, Hughes W, Watman R, Arnold B, Kronenberg H. Red cell folate assays: some answers to current problems with radio-assay variability. Pathology 1990;22:82-7.
69. 6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996;15:136-43.
70. 12, and folate. Am J Epidemiol 1996;143:845-59.
71. Savage DG, Lindenbaum J. Folate-cobalamin interactions. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker Inc, 1995:237-85.
72. Tucker KL, Mahnken B, Wilson PWF, Jacques P, Selhub J. Folic acid fortification of the food supply: potential benefits and risks for the elderly population. JAMA 1996;23:1879-85.
73. Bostom AG, Shemin D, Lapane KL, et al. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 1996;49:147-52.
74. Anthony AC. Megaloblastic anemia. In: Hoffman R, Benz EJ, Shultil SJ, et al, eds. Hematology: basic principles and practice. New York: Churchill Livinstone, 1991:392-421.
75. Lederle FA. Oral cobalamin for pernicious anemia, medicine's best kept secret? JAMA 1991;265:94-5.
76. 12 body stores during oral and parenteral treatment of pernicious anemia. Acta Med Scand 1978;204:81-4.
77. 12 without intrinsic factor in the treatment of pernicious anemia. Ann Intern Med 1963;58:810-7.
78. 12 serum levels in older people by oral treatment. J Am Geriatr Soc 1997;45:124-5.
79. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097-100.